/**
 * Drug reference database
 */

import { Drug } from '@/types';

export const drugs: Drug[] = [
  {
    id: 'desmopressin',
    name: 'Desmopressin (DDAVP)',
    genericName: 'desmopressin',
    class: 'ADH analog',
    mechanism: 'Synthetic vasopressin analog, binds V2 receptors in collecting duct → increases aquaporin-2 → water reabsorption',
    indications: ['central-DI'],
    contraindications: ['Nephrogenic DI (ineffective)', 'Hyponatremia', 'Polydipsia without DI'],
    dosing: 'IV/SC: 1-4 mcg q12-24h. PO: 0.1-0.8 mg daily. Intranasal: 10-40 mcg daily (educational ranges)',
    monitoring: ['Serum sodium (risk hyponatremia)', 'Urine output', 'Serum osmolality', 'Fluid balance'],
    adverseEffects: ['Hyponatremia (if excess water intake)', 'Headache', 'Nausea'],
    pearls: ['Allow "breakthrough" polyuria periodically to prevent hyponatremia', 'Patients need access to water'],
    whenToUse: 'Confirmed central DI with polyuria and hypernatremia',
    whenToAvoid: 'Nephrogenic DI (won\'t work), psychogenic polydipsia (will cause severe hyponatremia)',
  },
  {
    id: 'tolvaptan',
    name: 'Tolvaptan',
    genericName: 'tolvaptan',
    class: 'Vaptan (V2 receptor antagonist)',
    mechanism: 'Selective V2 receptor antagonist → blocks ADH effect → aquaresis (free water excretion without electrolytes)',
    indications: ['SIADH'],
    contraindications: ['Hypovolemic hyponatremia', 'Urgent correction needed', 'Liver disease (hepatotoxic)'],
    dosing: '15 mg PO daily initially, titrate to 30-60 mg (educational only)',
    monitoring: ['Serum sodium q4-6h initially (risk rapid rise)', 'LFTs (hepatotoxicity)', 'Volume status'],
    adverseEffects: ['Too-rapid Na correction', 'Thirst', 'Polyuria', 'Liver toxicity', 'Expensive'],
    pearls: ['SALT trial: improved QOL in SIADH', 'Risk over-correction → start in hospital', 'Not for acute symptomatic hypoNa'],
    whenToUse: 'Chronic SIADH refractory to fluid restriction, when can\'t restrict fluids (CHF)',
    whenToAvoid: 'Acute symptomatic hypoNa (too slow), hypovolemia, liver disease',
  },
  {
    id: 'fludrocortisone',
    name: 'Fludrocortisone',
    genericName: 'fludrocortisone',
    class: 'Mineralocorticoid',
    mechanism: 'Mineralocorticoid activity → Na retention in distal nephron',
    indications: ['CSW', 'adrenal-insufficiency'],
    contraindications: ['Hypervolemia', 'Heart failure', 'Hypertension'],
    dosing: '0.1-0.2 mg PO daily (educational range)',
    monitoring: ['Serum sodium', 'Blood pressure', 'Edema', 'Serum potassium (can drop)'],
    adverseEffects: ['Hypertension', 'Edema', 'Hypokalemia'],
    pearls: ['Useful adjunct in CSW with salt tabs', 'Takes days to work (not for acute management)'],
    whenToUse: 'CSW as adjunct to volume repletion and salt supplementation',
    whenToAvoid: 'SIADH (will worsen), CHF, uncontrolled HTN',
  },
  {
    id: 'amiloride',
    name: 'Amiloride',
    genericName: 'amiloride',
    class: 'Potassium-sparing diuretic (ENaC blocker)',
    mechanism: 'Blocks epithelial sodium channels (ENaC) → reduces lithium uptake in collecting duct cells',
    indications: ['nephrogenic-DI'],
    contraindications: ['Hyperkalemia', 'Renal failure'],
    dosing: '5-10 mg PO BID (educational)',
    monitoring: ['Serum potassium', 'Renal function', 'Urine output'],
    adverseEffects: ['Hyperkalemia', 'GI upset'],
    pearls: ['Specifically for lithium-induced NDI', 'Can reduce polyuria by ~50%', 'Allows continuation of lithium'],
    whenToUse: 'Lithium-induced nephrogenic DI when lithium must be continued',
    whenToAvoid: 'CKD stage 4-5, hyperkalemia',
  },
  {
    id: 'thiazide',
    name: 'Thiazide Diuretics',
    genericName: 'hydrochlorothiazide',
    class: 'Thiazide diuretic',
    mechanism: 'Paradoxical effect in NDI: mild volume depletion → increased proximal Na/water reabsorption → less delivery to collecting duct → reduced polyuria',
    indications: ['nephrogenic-DI'],
    contraindications: ['Hypovolemia', 'Hyponatremia'],
    dosing: 'HCTZ 25-50 mg daily + low-sodium diet (educational)',
    monitoring: ['Electrolytes (Na, K)', 'Volume status', 'Urine output'],
    adverseEffects: ['Hypokalemia', 'Hyponatremia', 'Volume depletion'],
    pearls: ['MUST combine with low-Na diet for effect', 'Can add amiloride for K-sparing', 'Reduces urine volume by 30-50%'],
    whenToUse: 'Nephrogenic DI (any cause) as first-line or adjunct to amiloride',
    whenToAvoid: 'Hyponatremia, severe hypovolemia',
  },
  {
    id: 'urea',
    name: 'Urea',
    genericName: 'urea',
    class: 'Osmotic agent',
    mechanism: 'Increases solute load → allows more free water excretion (osmotic diuresis of water)',
    indications: ['SIADH'],
    contraindications: ['Renal failure', 'Liver disease'],
    dosing: '15-30 g PO BID (educational)',
    monitoring: ['Serum sodium', 'BUN', 'Volume status'],
    adverseEffects: ['Bad taste', 'GI upset', 'Elevated BUN'],
    pearls: ['Alternative to fluid restriction in SIADH', 'Better tolerated than salt tabs for some', 'Not widely available in US'],
    whenToUse: 'SIADH when fluid restriction fails or not tolerated',
    whenToAvoid: 'Severe renal or liver dysfunction',
  },
  {
    id: 'hypertonic-saline',
    name: '3% Hypertonic Saline',
    genericName: 'sodium chloride 3%',
    class: 'Hypertonic crystalloid',
    mechanism: '513 mEq/L Na → raises serum sodium by providing concentrated sodium',
    indications: ['SIADH', 'CSW'],
    contraindications: ['Hypernatremia', 'Hypervolemia'],
    dosing: 'Bolus: 100-150 mL over 10-20 min for symptomatic hypoNa. Infusion: ~0.5-2 mL/kg/h (educational - must individualize)',
    monitoring: ['Serum sodium q2-4h', 'Neuro status', 'Correction rate', 'Volume status'],
    adverseEffects: ['Over-rapid correction (ODS)', 'Volume overload', 'Hypernatremia'],
    pearls: ['Use for symptomatic hypoNa (seizures, coma)', 'Target 4-6 mEq/L rise in 24h', 'Can use with furosemide in SIADH'],
    whenToUse: 'Acute symptomatic severe hyponatremia (<120, seizures), CSW with severe hypovolemia',
    whenToAvoid: 'Chronic asymptomatic hypoNa (too aggressive), beer potomania (will auto-correct)',
  },
];
